1 completed, 1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Corn oil control: new trials by email Literature Review of Corn oil control trials Research Report on Corn oil control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults Fish Oil, Corn oil control - Type 2 Diabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Phase 2 | Recruiting | May Faraj, PDt, PhD | 84 | 2026-10-05 | 2026-10-08 |
| Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease. Icosapent-ethyl ester capsules, Corn oil Control - Atherosclerosis Cardiovascular Disease | Not applicable | Not yet recruiting | University of Sao Paulo | 294 | 2025-04-01 | 2024-12-13 |
| Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia Epanova® (omega-3 carboxylic acids), corn oil control - Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) | Phase 3 | Completed | AstraZeneca | 13078 | 2014-10-30 | 2021-08-17 |
Atherosclerosis (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Glucose Intolerance (1) · Inflammation (1) · Insulin Resistance (1) · Obesity (1) · Overweight (1) · Prediabetic State (1)
AstraZeneca (1) · May Faraj, PDt, PhD (1) · University of Sao Paulo (1)
Canada (2) · Australia (1) · Belgium (1) · China (1) · Czechia (1) · Denmark (1) · Estonia (1) · Hungary (1) · Italy (1) · Japan (1) · Lithuania (1) · Mexico (1) · Netherlands (1) · New Zealand (1) · Poland (1)
May Faraj, P.Dt., Ph.D. (1) · Michael Lincoff, MD (1) · Stephen Nicholls, MD (1) · Steven Nissen, MD (1)
2014 (1)